Fitterfly personalises diabetes management with digital therapeutics

A.SingalA.Singal
BulletArticle
RED 2021 Healthcare Transformation
共有する：
リンクをコピーする
Fitterfly personalises diabetes management with digital therapeutics (RED 2021)

Fitterfly is an India-based company that provides solutions for chronic disease management. In this session, Fitterfly CEO and Co-Founder Dr Arbinder Singal discusses Diabefly, a digital therapeutics system that collects and analyses personal health data in order to deliver medical and lifestyle interventions.

Watch the full talk below.

共有する：
リンクをコピーする

同じトピックの記事

Gemii leverages WeChat to improve Chinese healthcare

Asia’s rapidly changing health insurance landscape (RED 2021)

おすすめのトピック

SequencingRED 2020Rare Diseases
次のおすすめ記事
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
3 steps to mitigate the impact of interference
  • Clinician Engagement, Coagulation, Disease Area, Management
3 steps to mitigate the impact of interference
A guide to balancing quality, speed and cost
  • Operational Excellence, Operations
A guide to balancing quality, speed and cost
Scroll to Top